Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-027985

Chief Financial Officer sold 319 shares at $13.11 ($4,182)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2023-06-12 Sale −319 $13.11 $4,182 86,222 D
Open-market sales · 319 sh · avg $13.11 · $4,182
Loading xslF345X04/ownership.xml…